Mubashir Farooqi
Psychiatry · Victorville, CANPI 1902858194
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 301 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $34.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$1K
- Neurocrine Biosciences, Inc.$859
- Johnson & Johnson$711
- Sunovion Pharmaceuticals Inc.$615
- plus $3K from 11 others
What the payments were for
- Food & beverage$10,295100%
- Education$510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $2,002 |
| Teva Pharmaceuticals USA, Inc. | 39 | $1,875 |
| Alkermes, Inc. | 39 | $1,396 |
| Neurocrine Biosciences, Inc. | 17 | $859 |
| Johnson & Johnson | 20 | $711 |
| Sunovion Pharmaceuticals Inc. | 29 | $615 |
| Otsuka America Pharmaceutical, Inc. | 27 | $550 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 7 | $463 |
| Axsome Therapeutics, Inc. | 4 | $403 |
| E.r. Squibb & Sons, L.L.C. | 4 | $327 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $280 |
| Lundbeck LLC | 14 | $207 |
| Vanda Pharmaceuticals Inc. | 8 | $184 |
| Indivior Inc. | 7 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Idorsia Pharmaceuticals US Inc | 2 | $141 |
| Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,346 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 12 | $86,188 |
| RexultiBrexpiprazole | 20 | $40,136 |
| LybalviOlanzapine/Samidorphan Malate | 25 | $39,888 |
| VraylarCariprazine Hcl | 21 | $36,839 |
| TrintellixVortioxetine Hydrobromide | 19 | $9,746 |
| Lurasidone Hcl | 44 | $2,584 |
| Bupropion XlBupropion Hcl | 53 | $2,476 |
| Asenapine Maleate | 13 | $2,461 |
| Aripiprazole | 117 | $2,276 |
| Vilazodone Hcl | 24 | $1,365 |
| Trazodone Hcl | 141 | $1,307 |
| Olanzapine | 61 | $1,053 |
| Clomipramine Hcl | 11 | $987 |
| Ziprasidone Hcl | 12 | $976 |
| Duloxetine Hcl | 35 | $645 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,875 | $86,18812 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $550 | $40,13620 claims |
| Alkermes, Inc.Lybalvi | $1,396 | $39,88825 claims |
| AbbVieVraylar | $2,002 | $36,83921 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $147 | $9,74619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Victorville
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.